Skip to content

An observational study investigating the treatment satisfaction of atopic dermatitis patients who have switched to ointment (W/O emulsion) formulation of Very Strong Class topical corticosteroids

An observational study investigating the treatment satisfaction of atopic dermatitis patients who have switched to ointment (W/O emulsion) formulation of Very Strong Class topical corticosteroids - Ointment treatment satisfaction for atopic dermatitis patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019873
Enrollment
60
Registered
2015-11-20
Start date
2015-11-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

None listed

Sponsors

Mie University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Female and male patients with a diagnosis of atopic dermatitis who are treated with Fatty Ointment Potency Class II(Very strong class) TCs 2) Patients who are scheduled to change the formulation of the Potency Class II TC from Fatty Ointment to Ointment (Water in Oil; W/O emulsion) as per investigator's routine treatment practice 3) Patients who are aged over 20 4) Patients who are able to understand and sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with any contraindication to TCs 2) Patients who are pregnant or breastfeeding 3) Patients who are regarded as ineligible by the investigator

Design outcomes

Primary

MeasureTime frame
Treatment satisfaction measured by Treatment Satisfaction Questionnaire for Medication (TSQM-9)

Secondary

MeasureTime frame
-Treatment adherence measured by Morisky Medication Adherence Scale (MMAS-8-Item) -Treatment effectiveness measured by Visual Analogue Scale (VAS) for itch and change in severity score measured by Severity Scoring of Atopic -Dermatitis (SCORAD) and Eczema Area and Severity Index (EASI).

Countries

Japan

Contacts

Public ContactKeiichi Yamanaka

Mie University Department of dermatology, Graduate school of medicine.

yamake@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026